Magnetic Barcode Imaging for MRI Contrast Agent Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current MRI technologies face challenges in visualizing contrast agents effectively, particularly in distinguishing between different tissues and pathologies due to limitations in image contrast interpretation and the difficulty in assigning colors to tissues based on varying T1 and T2 relaxation properties, as well as the challenge of co-localized contrast agents not emitting intrinsic signals.
Innovation Solution
The implementation of magnetic barcode imaging (MBI) using machine learning algorithms, specifically radial basis function neural networks, to generate T1, T2, and T2* maps, allowing for the unique identification, quantitation, and visualization of contrast agents by encoding their magnetic properties and molecular dynamics, enabling multi-color visualization and improved diagnostic power.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional MRI imaging is used to visualize contrast agents, then the imaging process is simple and fast, but the ability to distinguish between different contrast agents and their functional states is insufficient
Solution Approach 1:
The patent extends conventional single-parameter MRI imaging into a multi-dimensional parameter space by simultaneously measuring T1, T2, T2*, and susceptibility maps. This dimensional expansion creates a unique magnetic barcode signature for each contrast agent, enabling specific identification and functional state detection while maintaining the core MRI imaging approach.
Solution Approach 2:
The patent utilizes multiple relaxation parameters (T1, T2, T2*) and susceptibility measurements to characterize contrast agents. By monitoring changes in these parameters and their ratios, the system can distinguish between different contrast agents and detect functional states such as agent binding or activation, transforming single-parameter imaging into multi-parameter analysis.
2Loss of information
If multi-contrast agent imaging is performed using conventional MRI, then the diagnostic information increases, but the interpretation difficulty and image quality deteriorate due to signal overlap
Solution Approach 1:
The patent segments the complex task of multi-agent detection by assigning each contrast agent a unique magnetic barcode signature based on its specific T1, T2, T2*, and susceptibility characteristics. Machine learning algorithms are trained to recognize these segmented signatures, enabling clear differentiation between multiple co-administered contrast agents even when they are present simultaneously in the same imaging field.
3Adaptability or versatility
If traditional grayscale MRI images are used, then the imaging process is simple, but the diagnostic power and tissue differentiation capability are limited
Solution Approach 1:
The patent introduces a color-coding system where different colors represent different contrast agents or functional states. By mapping the multi-dimensional magnetic barcode parameters to color dimensions, the system transforms conventional grayscale imaging into color-coded visualizations that enhance diagnostic power and make it easier to distinguish between multiple agents and their functional states.
4Measurement precision
If machine learning algorithms are implemented for contrast agent identification, then the detection accuracy improves, but the computational complexity and processing time increase
Solution Approach 1:
The patent implements preliminary action by pre-training machine learning algorithms with synthetic magnetic barcode data generated from known contrast agent properties. This offline training phase creates ready-to-use classification models that can rapidly identify contrast agents during actual imaging without requiring complex real-time computation, thus reducing processing time while maintaining high accuracy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
MBI enables the specific detection and quantitation of contrast agents, overcoming traditional MRI limitations by providing enhanced diagnostic capabilities, allowing for the differentiation of contrast agents and their functional states, and facilitating multiplexing and multi-marker detection of pathologies without the need for radioactive agents.
Implementation Method 1
the relaxation rates of water in body tissue may be increased by adding paramagnetic metal ions (ions with unpaired electrons) to the tissue. The unpaired electrons in these metals greatly increase the relaxation rates of nearby water protons.
Implementation Method 2
Gadolinium (which causes a decrease in signal on T2-weighted images and an increase in signal on T1-weighted images) and superparamagnetic iron-oxide (which improves tumor contrast by decreasing the T2 signal in normal tissue) are known conventional contrast agents.
Implementation Method 3
Magnetic Resonance Imaging (MRI) is an imaging technique used in medicine. In this technique, images are obtained by applying a strong magnetic field, a magnetic-field gradient, and frequency-matched radio frequency (RF) pulses to a subject or sample. During the imaging process, atomic nuclei in the subject or sample, which have a magnetic moment and which are mostly protons, become excited by the RF radiation.
Implementation Method 4
When the RF pulse is stopped, relaxation of the excited nuclei causes emission of an RF signal that is detected. This signal is referred to as the free-induction decay (FID) response signal. As a result of applied magnetic-field gradients, the frequencies in this RF signal contain spatial information that are used to construct a gray scale image.
Data Source
AI summary
Provided herein is technology relating to magnetic resonance imaging contrast agents and particularly, but not exclusively, to methods and systems for visualizing one or more magnetic resonance imaging contrast agent.